John Salvucci

Managing Partner

John Salvucci is the Managing Partner of Lewis Brisbois’ Philadelphia office and the National Co-Chair of the Life Sciences Practice. He regularly associates in the defense of high-exposure cases. In this capacity, he often is brought in as a consultant tasked with developing an understanding of the key medical and scientific issues, identifying and retaining preeminent authorities, and formulating the defense strategy. In addition, Mr. Salvucci serves as national counsel in mass tort cases and has directly defended hundreds of claims on behalf of an array of clients.

Most recently, Mr. Salvucci was retained in a matter involving the death of four infants from a virus contracted while hospitalized at a world renowned children’s hospital. In addition, he is currently involved in the following complex matters:

  • A matter arising from the death of the chief executive of a major international corporation following surgery at a premier orthopedic hospital;
  • Over 25 ischemic stroke cases across more than 20 states, in which the strokes are alleged to have been associated with vertebral or carotid artery dissections;
  • Fifty-four spinal fusion cases that are being litigated in California, which are alleged to be tied to a counterfeit device manufacturing scheme; and
  • A case that has attracted national and international attention involving syndromes that have long confounded the medical and scientific communities.

In addition, Mr. Salvucci has defended numerous claims on behalf of a weight loss company, a medical device manufacturer of bone screws, and a processor of human bone allografts. Mr. Salvucci and his team also have served as national coordinating counsel for dental clinics and dialysis facilities. Moreover, they have analyzed and evaluated claims on a variety of topics including fungal meningitis arising from steroid injections, and most recently, addiction and death related to the use of opioids.

An influential thought leader, Mr. Salvucci presented a new theory associated with bone tissue infectivity before the 5th World Congress on Tissue Banking in Kuala Lumpur, Malaysia. His demonstration of expertise in the area of viral disease transmission resulted in an invitation from the International Atomic Energy Agency (IAEA) to join its biohazards committee. Mr. Salvucci became a member of an august group of 12 scientists and doctors from around the world who convened in Vienna, Austria, seen here. The committee developed protocols designed to address the remediation of materials contaminated with lethal pathogens for the member states of the United Nations.

Furthermore, Mr. Salvucci published an article in the European medical journal, Cell and Tissue Banking, which presented new theories regarding the transmission of AIDS and hepatitis. His conclusions were counter to what the medical and scientific communities had believed to be true for the past 60 years. However, Mr. Salvucci’s new theories are gaining traction, as they have been cited as authoritative by doctors and scientists in the United States, Spain, China, Turkey, Italy, Denmark, Sweden, Brazil, Germany, and England. Likewise, a new book on the topic of tissue banking contains a chapter that Mr. Salvucci authored on viral disease transmission.

Primary Area(s) of Practice

  • Healthcare
  • Life Sciences
  • Italy Practice
  • COVID-19: FDA Regulatory/Life Sciences



U.S. District Court, Eastern District of Pennsylvania

U.S. Supreme Court

Awards & Honors

  • Listed in Best Lawyers in America® 2023-2024 — Insurance Law
  • Philadelphia's Top Rated Lawyers™ of 2014


Rutgers, The State University of New Jersey School of Law

Juris Doctor, 1978

Kenyon College

Bachelor of Arts, magna cum laude, 1975